GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Additional Paid-In Capital

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Additional Paid-In Capital?


Tonghua Golden-horse Pharmaceutical Industry Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥2,902 Mil) but then stayed the same from Dec. 2023 (¥2,902 Mil) to Mar. 2024 (¥0 Mil).

Tonghua Golden-horse Pharmaceutical Industry Co's annual additional paid-in capital stayed the same from Dec. 2021 (¥2,965 Mil) to Dec. 2022 (¥2,965 Mil) but then declined from Dec. 2022 (¥2,965 Mil) to Dec. 2023 (¥2,902 Mil).


Tonghua Golden-horse Pharmaceutical Industry Co Additional Paid-In Capital Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co Additional Paid-In Capital Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,965.43 2,965.43 2,965.43 2,965.43 2,902.30

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2,965.43 - 2,902.30 -

Tonghua Golden-horse Pharmaceutical Industry Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Tonghua Golden-horse Pharmaceutical Industry Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines